EXHIBIT 99-1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, par value $0.001 per share, of Paratek Pharmaceuticals, Inc., a Delaware corporation, and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filings.

The undersigned further agree that each party hereto is responsible for the timely filing of such Statement on Schedule 13G and any amendments thereto, and for the accuracy and completeness of the information concerning such party contained therein; provided, however, that no party is responsible for the accuracy or completeness of the information concerning any other party, unless such party knows or has reason to believe that such information is inaccurate.

This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.

[Signature Page Follows]

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of March 11, 2022.

DRUGCRAFTERS, LP
	By:	/s/ James D. Dondero
		Name:  James D. Dondero
		Title:  Managing Member of the General Partner
HIGHLAND SMALL-CAP EQUITY FUND
	By:	/s/ Frank Waterhouse
		Name:  Frank Waterhouse
		Title:  Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer and Treasurer
NexPoint Real Estate Opportunities, LLC
	By:	/s/  Brian Mitts
		Name:  Brian Mitts
		Title: Authorized Signatory

THE DUGABOY INVESTMENT TRUST
By:	/s/ Nancy Dondero
Name:  Nancy Dondero
Title:  Trustee
/s/ James D. Dondero
James D. Dondero